Depo-Provera and Where Drug Preemption Stops Thousands of plaintiffs allege that long-term use of Depo-Provera, manufactured by Pfizer, caused meningioma brain tumors
Additionally, in phase 2 studies in people with MASH and liver fibrosis, survodutide not only significantly improved liver steatosis, but also led to histologic improvement of MASH without worsening fibrosis in 4362% of participants, versus 14% with placebo [41]
Because GLP-1 slows down digestion, some patients may experience mild gastrointestinal side effects like nausea, mild stomach discomfort, or changes in bowel habits, especially when first starting
As the majority of patients with type 2 diabetes are overweight or obese this offers a potential advantage over older, established therapies, and DPP-4 inhibitors are being used in clinical practice as second-line therapy in addition to metformin in overweight and obese patients who fail to reach glycemic targets with metformin monotherapy
This rare tumor was first described by Millar in 1932, as a "malignant melanotic tumor of the ganglion cells arising from the thoracic sympathetic ganglion." 13 It was later identified as a subtype of schwannoma in 1961 by Hodson 34 before subsequently being termed "melanocytic schwannoma" in 1975 by Fu et al
More details Discover other ingredients